The Evolution of STI Testing: A Catalyst for Modern Diagnostic Technologies
Next-Generation Molecular Platforms: CRISPR and Multimodal Diagnostics A new wave of molecular innovation is emerging in STI diagnostics, led by CRISPR-based platforms and multimodal assay designs. Systems such as SHERLOCK and DETECTR pair gene-targeted precision with rapid, streamlined workflows that are well-suited to decentralized and low-resource environments. When combined with isothermal amplification methods like LAMP or RPA, these CRISPR platforms can deliver visual or lateral flow readouts within minutes while maintaining the sensitivity expected from laboratory-grade molecular tests.
strategies that pair the ease of lateral flow with the added assurance of nucleic acid detection. This shift is giving developers new ways to streamline workflows and deliver higher-level diagnostic performance without relying on traditional laboratory infrastructure.
Meanwhile, multimodal assay formats are beginning to blur the line between rapid testing and molecular confirmation, using hybrid signal
Stable by Design: Ambient-Temperature Assays
Cold-chain dependence remains one of the biggest practical barriers to scaling molecular STI diagnostics. Enzymes and master mixes that require frozen storage limit where testing can occur and add substantial cost and complexity across the supply chain. New approaches in reagent stabilization technologies are opening the door to far more flexible deployment models. Lyophilizable or air-dryable formulations, as well as liquid mixes that stay stable at ambient temperatures for extended periods, are making it possible to support testing in a broader range of environments.
As a result, developers can now build temperature- stable kits that offer meaningful advantages: • Differentiated kit design: Ambient-stable reagents extend shelf-life and simplify packaging, giving developers a competitive edge in global distribution and procurement. • Workflow reliability: Pre-aliquoted, ready-to-use mixes minimize user error and variation, strengthening confidence in assay performance.
24 | GENengnews.com
Powered by FlippingBook